Advertisement

Topics

"Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin" Drugs and Medication Database

04:07 EST 16th February 2019 | BioPortfolio

Here are the most relevant "Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin" Drugs and Medications that we have found in our database.

More Information about "Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin" on BioPortfolio

We have published hundreds of Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin news stories on BioPortfolio along with dozens of Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin Clinical Trials and PubMed Articles about Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin Companies in our database. You can also find out about relevant Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin Drugs and Medications on this site too.

Showing "Safety Efficacy Aprepitant Ramosetron Dexamethasone Chemotherapy Induced Nausea" Drugs and Medications 1–25 of 465

Probably Relevant

Granisetron hydrochloride [wockhardt limited]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intraveno

Granisetron hydrochloride [wockhardt limited]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intraveno

Granisetron hydrochloride [wockhardt limited]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intraveno

Aprepitant [glenmark pharmaceuticals inc., usa]

These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral use Initial U.S. Approval: 2003

Emend [merck sharp & dohme corp.]

These highlights do not include all the information needed to use EMEND FOR INJECTION safely and effectively. See full prescribing information for EMEND FOR INJECTION. EMEND (fosaprepitant) for injection, for intravenous useInitial U.S. Approval: 2008

Aprepitant [sandoz inc]

These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral useInitial U.S. Approval: 2003

Emend [physicians total care, inc.]

These highlights do not include all the information needed to use EMEND safely and effectively. See full prescribing information for EMEND. EMEND (aprepitant) CapsulesInitial U.S. Approval: 2003

Emend [rebel distributors corp]

These highlights do not include all the information needed to use EMEND safely and effectively. See full prescribing information for EMEND. EMEND (aprepitant) CapsulesInitial U.S. Approval: 2003

Possibly Relevant

Granisetron [fresenius kabi usa, llc]

These highlights do not include all the information needed to use GRANISETRON HYDROCHLORIDE INJECTION, USP safely and effectively.  See full prescribing information for GRANISETRON HYDROCHLORIDE INJECTION, USP. GRANISETRON HYDROCHLORIDE INJECTION, USP fo

Emend [merck sharp & dohme corp.]

These highlights do not include all the information needed to use EMEND FOR INJECTION safely and effectively. See full prescribing information for EMEND FOR INJECTION. EMEND (fosaprepitant) for injection, for intravenous use Initial U.S. Approval: 2008

Granisetron hydrochloride [sagent pharmaceuticals]

These highlights do not include all the information needed to use granisetron hydrochloride safely and effectively. See full prescribing information for granisetron hydrochloride. GRANISETRON hydrochloride injection, USP, for intravenous use Initial U.S.

Emend [merck sharp & dohme corp.]

These highlights do not include all the information needed to use EMEND CAPSULES and EMEND FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EMEND CAPSULES and EMEND FOR ORAL SUSPENSION. EMEND (aprepitant) capsules, for oral

Cinvanti [heron therapeutics, inc.]

These highlights do not include all the information needed to use CINVANTI safely and effectively. See full prescribing information for CINVANTI. CINVANTI (aprepitant) injectable emulsion, for intravenous useInitial U.S. Approval: 2003

Granisetron hydrochloride [mylan institutional llc]

These highlights do not include all the information needed to use GRANISETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for GRANISETRON HYDROCHLORIDE INJECTION. GRANISETRON hydrochloride injection, for intravenous u

Ondansetron [taro pharmaceuticals u.s.a., inc.]

These highlights do not include all the information needed to use ONDANSETRON ORAL SOLUTION safely and effectively. See full prescribing information for ONDANSETRON ORAL SOLUTION ONDANSETRON oral solutionInitial U.S. Approval: 1991

Ondansetron [nucare pharmaceuticals,inc.]

These highlights do not include all the information needed to use ONDANSETRON ORAL SOLUTION safely and effectively. See full prescribing information for ONDANSETRON ORAL SOLUTION ONDANSETRON oral solution Initial U.S. Approval: 1991

Ondansetron [unit dose services]

These highlights do not include all the information needed to use ONDANSETRON ORAL SOLUTION safely and effectively. See full prescribing information for ONDANSETRON ORAL SOLUTION ONDANSETRON oral solutionInitial U.S. Approval: 1991

Farydak [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use FARYDAK safely and effectively. See full prescribing information for FARYDAK. FARYDAK (panobinostat) capsules, for oral use Initial U.S. Approval: 2015

Granisetron hydrochloride [wockhardt usa llc.]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. GRANISETRON hydrochloride injection USP, for intravenou

Granisetron hydrochloride [wockhardt usa llc.]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. GRANISETRON hydrochloride injection USP, for intravenou

Granisetron hydrochloride [wockhardt usa llc.]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. GRANISETRON hydrochloride injection USP, for intravenou

Pemetrexed [qilu pharmaceutical co., ltd.]

These highlights do not include all the information needed to use Pemetrexed for Injection safely and effectively. See full prescribing information for Pemetrexed for Injection. PEMETREXED for injection, for Intravenous Use Initial U.S. Approval: 2004

Ondansetron hydrochloride [taro pharmaceuticals u.s.a., inc.]

These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS ONDANSETRON tablets, for oral use Initial U.S. Approval: 1991

Palonosetron [northstar rx llc]

These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION.  PALONOSETRON HYDROCHLORIDE injection, for Intraveno

Aranesp [amgen inc]

These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP .     ARANESP (darbepoetin alfa )   i njection, for intravenous or subcutaneous use Initial U.S. Approval: 2



Advertisement
Quick Search
Advertisement
Advertisement